Your browser doesn't support javascript.
loading
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.
Parry, Marina A; Srivastava, Shambhavi; Ali, Adnan; Cannistraci, Alessio; Antonello, Jenny; Barros-Silva, João Diogo; Ubertini, Valentina; Ramani, Vijay; Lau, Maurice; Shanks, Jonathan; Nonaka, Daisuke; Oliveira, Pedro; Hambrock, Thomas; Leong, Hui Sun; Dhomen, Nathalie; Miller, Crispin; Brady, Ged; Dive, Caroline; Clarke, Noel W; Marais, Richard; Baena, Esther.
Afiliación
  • Parry MA; Molecular Oncology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Srivastava S; Molecular Oncology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Computational Biology, Cancer Research UK Manchest
  • Ali A; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Genitourinary Cancer Research Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manch
  • Cannistraci A; Molecular Oncology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Antonello J; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Barros-Silva JD; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Ubertini V; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Ramani V; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK.
  • Lau M; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK.
  • Shanks J; Department of Pathology, The Christie NHS Foundation Trust, Manchester, UK.
  • Nonaka D; Department of Pathology, The Christie NHS Foundation Trust, Manchester, UK.
  • Oliveira P; Department of Pathology, The Christie NHS Foundation Trust, Manchester, UK.
  • Hambrock T; Department of Radiology, The Christie NHS Foundation Trust, Manchester, UK.
  • Leong HS; Computational Biology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Dhomen N; Molecular Oncology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Miller C; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Computational Biology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; RNA Biology, Cancer Research UK Manchester Inst
  • Brady G; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Dive C; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Clinical and Experimental Pharmacology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Clarke NW; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Genitourinary Cancer Research Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manch
  • Marais R; Molecular Oncology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. Electronic address: richard.marais@cruk.manchester
  • Baena E; Belfast-Manchester Movember Centre of Excellence, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK; Prostate Oncobiology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. Electronic address: esther.baena@cruk.manchester
Eur Urol Oncol ; 2(1): 1-11, 2019 02.
Article en En | MEDLINE | ID: mdl-30929837
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Genómica / Imágenes de Resonancia Magnética Multiparamétrica Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Genómica / Imágenes de Resonancia Magnética Multiparamétrica Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido